Joseph Proebstle
Podiatrist · Pasadena, MDNPI 1972501906
Payments from drug & device makers
Across 64 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$429
- Paratek Pharmaceuticals, Inc.$108
- Nevro Corp.$64
- Melinta Therapeutics, LLC$59
- Amgen$48
- Treace Medical Concepts, Inc.$45
- plus $225 from 10 others
What the payments were for
- Food & beverage$978100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 32 | $429 |
| Paratek Pharmaceuticals, Inc. | 7 | $108 |
| Nevro Corp. | 4 | $64 |
| Melinta Therapeutics, LLC | 3 | $59 |
| Amgen | 3 | $48 |
| Treace Medical Concepts, Inc. | 1 | $45 |
| Integra Lifesciences Corporation | 2 | $36 |
| Organogenesis Inc. | 1 | $29 |
| Kerecis Limited | 2 | $24 |
| TEI Medical Inc. | 2 | $23 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $23 |
| Averitas Pharma Inc. | 1 | $22 |
| Nabriva Therapeutics, PLC | 1 | $20 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
| Heron Therapeutics, Inc. | 1 | $16 |
| Triad Life Sciences Inc. | 1 | $12 |
How this compares
$978 in reported general payments places this provider in the 55th percentile of 183 podiatrist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 13 | $356 |
| Doxycycline Hyclate | 17 | $261 |
| Silver Sulfadiazine | 11 | $155 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $151 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Pasadena
- Ira GottliebPasadena$4.6M
- Enzo LeonePasadena$15K
- Jenny NguyenPasadena$15K
- Ross CohenPasadena$8K
- Steven GershPasadena$2K
- Ijeoma NwujuBethesda$601K
- David Linla Plata$75K
- Teresa HilliardHyattsville$19K
- Andreas KaikisHagerstown$17K
- Tiffany HohBaltimore$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.